A series of mega-blockbuster drugs are on the horizon. How to invest in the trend

Biopharma companies are having more clinical success treating Alzheimer’s and obesity, and are pursuing new approaches in oncology, creating more mega-blockbuster drugs, according to Bank of America. Analyst Geoff Meacham has identified 20 drugs that have the potential to generate $10 billion or more in annual sales by 2030 within the universe of companies it …

A series of mega-blockbuster drugs are on the horizon. How to invest in the trend Read More »